Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial

[1] Baeten JM(2013)Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr 63 S122-S129

[2] Haberer JE(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599

[3] Liu AY(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 381 2083-2090

[4] Sista N(2012)Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis Antivir Ther 17 1483-1493

[5] Grant RM(2012)Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 423-434

[6] Lama JR(2003)Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus Clin Infect Dis 36 1070-1073

[7] Anderson PL(2004)Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases J Acquir Immune Defic Syndr 35 269-273

[8] McMahan V(2004)Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution AIDS (London, England) 18 351-352

[9] Liu AY(2009)Progressive renal tubular dysfunction associated with long-term use of tenofovir DF AIDS Res Hum Retrovir 25 387-394

[10] Vargas L(2010)Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients J Acquir Immune Defic Syndr 53 62-69

[1] Baeten JM(2013)Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr 63 S122-S129

[2] Haberer JE(2010)Preexposure chemoprophylaxis for HIV prevention in men who have sex with men N Engl J Med 363 2587-2599

[3] Liu AY(2013)Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial Lancet 381 2083-2090

[4] Sista N(2012)Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis Antivir Ther 17 1483-1493

[5] Grant RM(2012)Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana N Engl J Med 367 423-434

[6] Lama JR(2003)Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus Clin Infect Dis 36 1070-1073

[7] Anderson PL(2004)Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases J Acquir Immune Defic Syndr 35 269-273

[8] McMahan V(2004)Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution AIDS (London, England) 18 351-352

[9] Liu AY(2009)Progressive renal tubular dysfunction associated with long-term use of tenofovir DF AIDS Res Hum Retrovir 25 387-394

[10] Vargas L(2010)Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients J Acquir Immune Defic Syndr 53 62-69